Skip to content

Max Samuel Rosen, MD

NPI 1255715793ActiveIndividual· Psychiatry & Neurology, Child & Adolescent Psychiatry· Saint Louis, MO

Psychiatry & Neurology, Child & Adolescent Psychiatry (MD) in Saint Louis, Missouri, licensed in MO, with an NPI issued in July 2015. Part D covered 14 prescriptions written in 2024, 100% of them generic. Supernus Pharmaceuticals, Inc. reported $23.05 in payments in 2025, mostly food and beverage.

Overview

NPI1255715793
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 15, 2015
Last updated in NPPESApr 17, 2025
Certified by providerJul 6, 2020

Specialties and licenses

TaxonomyCodeLicenseState
Psychiatry & Neurology, Child & Adolescent Psychiatry Primary2084P0804X2017005242MO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Psychiatry (MO)

Part D prescriptions in 2024

Prescriptions (claims)14 · 14 30-day fills
Total drug cost$278.90
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$23.05 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Supernus Pharmaceuticals, Inc.$23.051

What the 2025 payments were for

  • Food and Beverage$23.05 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other child and adolescent psychiatrists in Saint Louis

All 72 child and adolescent psychiatrists in Saint Louis · All child and adolescent psychiatrists in Missouri